trending Market Intelligence /marketintelligence/en/news-insights/trending/vra70bk7hnle4yo4fk1t_a2 content esgSubNav
In This List

Tetra Bio-Pharma completes acquisition of PhytoPain Pharma

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022


Tetra Bio-Pharma completes acquisition of PhytoPain Pharma

Tetra Bio-Pharma Inc. said it completed the acquisition of the remaining 20% of PhytoPain Pharma Inc. for C$12.4 million.

The Canadian medical cannabis company paid C$248,000 in cash, C$2.2 million in promissory notes and issued 2,485,218 of its shares for the interest.